Abraxane Injection, Powder, Lyophilized, For Suspension
Product Images NDC 68817-134
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Abraxane (NDC 68817-134). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Abraxis Bioscience, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Structural Formula For Paclitaxel (Abraxane 02)
Figure 1: Kaplan-meier Curve Of Overall Survival (intent-to-treat Population) (Abraxane 03)
This appears to be a table representing the proportion of survival over time (in months) for two different groups (Amx/cEM and GaM), with the number of participants at risk at each time point listed. The percentages in the last row may represent the overall survival rate at the end of the observation period.*
Principal Display Panel (100 mg Vial)
Principal Display Panel (100 mg Vial)
Principal Display Panel (100 mg Vial Carton)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.